Becerra orders CMS to rethink $22 Medicare Part B premium price hike tied to Aduhelm
By
Alicia Lasek
Jan 11, 2022
With the 50% price drop of Aduhelm on January 1, there is good reason for CMS to reassess a hefty proposed premium hike for 2022, the U.S. health secretary said. On Wednesday, CMS is expected to announce...
CMS restricts coverage of Alzheimer’s drug Aduhelm to clinical trials
By
Alicia Lasek
Apr 08, 2022
Coverage of aducanumab (Aduhelm) is officially limited to clinical trials only, the agency announced Thursday. Most stakeholders have called for restricted use while more efficacy and safety data is gathered,...
Eli Lilly expects Medicare about-face on Alzheimer’s drugs coverage
By
Alicia Lasek
Apr 23, 2023
New data on Lilly’s experimental drug donanemab may influence CMS’s restrictive stance on coverage of this and other amyloid-busting Alzheimer’s treatments, a company executive says.
AHCA/NCAL to CMS: Safeguard temporary nurse aide jobs by reissuing employment waiver
By
Alicia Lasek
Oct 04, 2022
The industry advocate is urging CMS to reissue a blanket waiver that would allow nursing homes to employ temporary nurse aides beyond the public health emergency.
CMS to begin audits for schizophrenia coding, says citations will affect quality ratings
By
Alicia Lasek
Jan 19, 2023
The agency will start auditing nursing homes this month to determine whether residents’ schizophrenia diagnoses are accurate and appropriately coded. A pattern of inaccurate coding may result in a quality...